Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1999
08/26/1999WO1999042129A1 Purified sperm surface antigen, monoclonal antibody therefor and application therefor
08/26/1999WO1999042127A2 Receptor derived peptides as modulators of receptor activity
08/26/1999WO1999042123A1 Method of promoting neuronal cell proliferation and diffrentiation
08/26/1999WO1999042116A1 Novel disulfides and thiol compounds
08/26/1999WO1999042115A1 Use of a press-juice, digestive juice or extract of carnivorous plants for inhibiting protein kinases
08/26/1999WO1999042112A1 Process for preparing solid preparation by using colloid of platinum and palladium as main raw material and use thereof
08/26/1999WO1999042108A1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system
08/26/1999WO1999042107A1 Piperazine derivatives for treating bone deficit conditions
08/26/1999WO1999042102A1 Indole-3-propionic acids, salts and esters thereof used as medicaments
08/26/1999WO1999042101A1 Dietary control of arachidonic acid metabolism
08/26/1999WO1999042099A1 Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
08/26/1999WO1999042098A1 Small molecules that increase the conversion of food to body weight gain
08/26/1999WO1999042097A1 Small molecules that elicit a polarized th1 response and for modulation of cellular immunity
08/26/1999WO1999042095A1 Pharmaceutical combinations containing tramadol
08/26/1999WO1999042089A2 Use of thiadiazolo[4,3-a]pyridine derivatives
08/26/1999WO1999042088A2 Method for the treatment of diseases or disorders of the inner ear
08/26/1999WO1999042085A1 Erythropoietin liposomal dispersion
08/26/1999WO1999042075A2 Antibodies against human cd40
08/26/1999WO1999041985A1 P53-dependent secretion of growth inhibitory factors
08/26/1999WO1999031136A3 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
08/26/1999WO1999030697A3 Combination effective for the treatment of impotence
08/26/1999WO1999027094A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
08/26/1999WO1999026909A3 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
08/26/1999WO1999026609A3 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
08/26/1999WO1999024462A3 Novel conjugates of rgd-containing peptides and endogenous carriers
08/26/1999WO1999022720A3 Selective cyclooxygenase-2 inhibitors against premature labor
08/26/1999WO1998030696A8 Secreted proteins and polynucleotides encoding them
08/26/1999DE19909251A1 Agents for treating human diseases, particularly cancer, modulate interaction of beta-catenin with transcription factors or tumor suppressor gene products
08/26/1999DE19808634A1 Production of pharmaceutical pellets, especially containing iloprost, with stabilized release properties
08/26/1999DE19807535A1 Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying
08/26/1999DE19807423A1 New isoindolone derivatives useful as soluble guanylate cyclase activators for treating cardiovascular disorders, asthma, renal insufficiency, diabetes, cirrhosis or cognitive dysfunction
08/26/1999CA2687533A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999CA2357015A1 Agents for treating human illnesses based on .beta.-catenin, and the production and use thereof
08/26/1999CA2322200A1 Receptor derived peptides as modulators of receptor activity
08/26/1999CA2321961A1 Novel disulfides and thiol compounds
08/26/1999CA2321814A1 Small molecules that increase the conversion of food to body weight gain
08/26/1999CA2321783A1 Use of an expressed juice, digestive juice or extract from flesh-eating plants for the inhibition of protein kinases
08/26/1999CA2321498A1 Pharmaceutical preparations for the selectively supplementing oestrogen deficiency in the central nervous system
08/26/1999CA2321278A1 Novel compounds
08/26/1999CA2321224A1 Phosphodiesterase 10
08/26/1999CA2321182A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists
08/26/1999CA2321165A1 Antibodies against human cd40
08/26/1999CA2321140A1 Inhibitors of complement activation
08/26/1999CA2321104A1 Azole peptidomimetics as thrombin receptor antagonists
08/26/1999CA2321052A1 Process for the obtaining of hmg-coa reductase inhibitors of high purity
08/26/1999CA2320799A1 Secreted proteins and polynucleotides encoding them
08/26/1999CA2320632A1 Caf1-related protein
08/26/1999CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
08/26/1999CA2320354A1 Novel compounds and their use as positive ampa receptor modulators
08/26/1999CA2319039A1 Biotin-binding receptor molecules
08/26/1999CA2318836A1 Histamine h3 receptor ligands
08/26/1999CA2318818A1 Fermentative preparation process for cytostatics and crystal forms thereof
08/26/1999CA2318811A1 Modulation of cell proliferation, methods and reagents
08/26/1999CA2318237A1 Use of thiadiazolo[4,3-a]pyridine derivatives
08/26/1999CA2288178A1 Piperazine derivatives for treating bone deficit conditions
08/25/1999EP0937779A2 Cell damage marker
08/25/1999EP0937777A2 GABA receptors and their uses
08/25/1999EP0937734A1 11-Acetyl-12,13-dioxabicyclo [8.2.1] tridecenone derivatives, process for making them and pharmaceutical compositions containing them
08/25/1999EP0937722A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors
08/25/1999EP0937708A2 sulphonamide derivatives
08/25/1999EP0937464A2 Combined pharmaceutical preparation containing inhibitors of the sodium hydrogen exchange and a medicament for the treatment of cardiovascular diseases
08/25/1999EP0937458A2 Pyrrolidine and piperidine derivatives
08/25/1999EP0937456A1 Erythropoietin liposomal dispersion
08/25/1999EP0937144A1 Human eosinophil-derived basic protein
08/25/1999EP0937143A2 Secreted proteins and polynucleotides encoding them
08/25/1999EP0937141A1 Polynucleotides encoding secreted proteins from human dendritic cells
08/25/1999EP0937140A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule
08/25/1999EP0937103A2 Compounds and methods for modulating cell adhesion
08/25/1999EP0937093A2 1-galactose derivatives
08/25/1999EP0937089A1 New knoevenagel condensation products, method for their production and their use
08/25/1999EP0937077A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
08/25/1999EP0937075A1 New imidazopyridines and oxazolopyridines
08/25/1999EP0937073A2 Selective factor xa inhibitors
08/25/1999EP0937069A1 Piperazino derivatives as neurokinin antagonists
08/25/1999EP0937065A1 Constrained somatostatin agonists and antagonists
08/25/1999EP0937064A1 Substituted oximes derivatives useful as neurokinin antagonists
08/25/1999EP0937053A1 Sustained-release derivatives of hydroxylated analogs of substituted 1- 2 bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake
08/25/1999EP0937047A1 1-arylphthalazine antagonists of excitatory amino acid receptors
08/25/1999EP0937045A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
08/25/1999EP0937044A1 Cftr channel activator compounds and pharmaceutical compositions containing same
08/25/1999EP0937042A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors
08/25/1999EP0937041A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments
08/25/1999EP0937040A2 N-substituted 2-cyanopyrrolidines
08/25/1999EP0937037A1 Sodium salt of poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof
08/25/1999EP0937036A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
08/25/1999EP0937035A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
08/25/1999EP0936914A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors
08/25/1999EP0936912A1 Inhibitors of cysteine protease
08/25/1999EP0936911A1 Adenosine deaminase inhibitors
08/25/1999EP0667858B1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists
08/25/1999EP0646016B1 Synthetic peptides for the treatment of myasthenia gravis
08/25/1999EP0612321B1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity
08/25/1999EP0602211B1 Use of growth factor igf-ii for the treatment of gastrointestinal disorders
08/25/1999EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor
08/25/1999CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof
08/25/1999CN1226893A Selected derivatives of K-252a
08/25/1999CN1226892A Compounds and compositions for treating diseases associated with tryptase activity
08/25/1999CN1226835A -i gene transfer methods for wound healing
08/25/1999CN1226831A Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine
08/25/1999CN1226830A Egg anti-inflammatory composition, method of isolation and use
1 ... 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 ... 1564